Skip to main content
HCPCS J0884 · Level II · Part B drug

J0884: argatroban, ESRD on dialysis, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0884

Billing unit
1 MG
Argatroban esrd dialysis 1mg
ASP payment limit
$0.772
October 2026; -10.7% vs July 2026
Practitioner MUE
1125
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0884 is the Level II code for Injection, argatroban, 1 mg (for esrd on dialysis), billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.772 per billing unit, down 10.7% from July 2026. The practitioner MUE allows up to 1125 units per date of service (MAI 3), so a full 1125-unit day is $868.50 at the current limit. Under OPPS it carries status indicator N. Because the descriptor is specific to ESRD patients on dialysis, Medicare expects the drug inside the ESRD prospective payment bundle when furnished by the dialysis facility, and separate Part B billing applies only outside that setting. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names argatroban: J0883 (for non-ESRD use); J0898 (for non-ESRD use; the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0883); J0899 (the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0884). The ASP crosswalk maps 10 NDCs to it, sold as Argatroban by Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals, Endo USA, Inc. No current Billing and Coding Article lists J0884, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0884 at $0.772 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.864 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0884
QuarterPayment limitPerCoinsurance
October 2026$0.7721 MG20%
July 2026$0.8641 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 10 NDCs from 7 labelers to J0884. Report the NDC in the claim's drug segment and bill the number of J0884 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J0884
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9377-01ArgatrobanHikma Pharmaceuticals USA Inc.50 × 150
00143-9559-01ArgatrobanHikma Pharmaceuticals USA Inc.50 × 150
00143-9674-01ArgatrobanHikma Pharmaceuticals USA Inc.2.5 × 1250
25021-0414-50ArgatrobanSagent Pharmaceuticals50 × 150
42023-0182-01ArgatrobanEndo USA, Inc.2.5 × 1250
42023-0182-89ArgatrobanEndo USA, Inc.2.5 × 1250
65145-0126-01ArgatrobanCaplin Steriles USA Inc.50 × 150
65219-0429-50ArgatrobanFreseniUS Kabi USA, LLC50 × 150
67457-0212-02ArgatrobanMylan Institutional LLC2.5 × 1250
83301-0062-01ArgatrobanMullan Pharmaceutical Inc.50 × 150

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0884. For practitioners the limit is 1125 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0884 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services11253 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital12503 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0884 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0884 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0884 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0884 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0884 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0884 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0884 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0884 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0884

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0884

What does HCPCS code J0884 describe?

J0884 is defined by CMS as "Injection, argatroban, 1 mg (for esrd on dialysis)". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0884 a CPT code?

No. J0884 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as argatroban; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0884 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0884 in October 2026?

The ASP-based payment limit is $0.772 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.864. Commercial payers use their own fee schedules.

How many units of J0884 can be billed per day?

The practitioner Medically Unlikely Edit is 1125 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 1250. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J0884?

The October 2026 ASP crosswalk lists 10 NDCs from 7 labelers: Argatroban (Hikma Pharmaceuticals USA Inc.); Argatroban (Sagent Pharmaceuticals); Argatroban (Endo USA, Inc.); Argatroban (Caplin Steriles USA Inc.). For example NDC 00143-9377-01 (package size 50) equals 50 billing units of J0884.

Does J0884 have NCCI bundling edits?

No active practitioner PTP pairs list J0884 as a column-1 or column-2 code in the v323r0 release.

J0884 vs J0883: what is the difference?

Both are HCPCS Level II codes whose descriptor names argatroban. What sets J0883 apart: for non-ESRD use. J0884 is billed per 1 mg, limit $0.772, MUE 1125; J0883 is billed per 1 mg, limit $0.772, MUE 1125. Report the code whose descriptor matches the product and setting in the record.

J0884 vs J0898: what is the difference?

Both are HCPCS Level II codes whose descriptor names argatroban. What sets J0898 apart: for non-ESRD use; the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0883. J0884 is billed per 1 mg, limit $0.772, MUE 1125; J0898 is billed per 1 mg, limit $1.206. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.